Early and accurate diagnosis of pancreatic cancer? Read more about Early and accurate diagnosis of pancreatic cancer?
Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface. Read more about Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surface.
Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Read more about Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming. Read more about Transcriptomic-metabolomic reprogramming in EGFR-mutant NSCLC early adaptive drug escape linking TGFβ2-bioenergetics-mitochondrial priming.
Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas. Read more about Gli promotes epithelial-mesenchymal transition in human lung adenocarcinomas.
GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity. Read more about GBM heterogeneity as a function of variable epidermal growth factor receptor variant III activity.
Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer. Read more about Hypoxia-induced CCL28 promotes recruitment of regulatory T cells and tumor growth in liver cancer.
Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model. Read more about Concurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma model.
Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia. Read more about Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia.
IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance. Read more about IKK/NF-κB signaling contributes to glioblastoma stem cell maintenance.
